Lack of 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice
暂无分享,去创建一个
Kiyotaka Okada | Osamu Matsuo | Keiichi Nakajima | A. Ishisaki | O. Kozawa | K. Okada | O. Matsuo | H. Matsuno | S. Ueshima | Hiroyuki Matsuno | Akira Ishisaki | Shigeru Ueshima | Osamu Kozawa | K. Nakajima
[1] D. Gospodarowicz,et al. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT‐20 cells. , 1989, The EMBO journal.
[2] N. Ferrara,et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.
[3] M. Karkkainen,et al. Lymphatic endothelium: a new frontier of metastasis research , 2002, Nature Cell Biology.
[4] J. Isner,et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. , 1995, Circulation.
[5] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[6] A. Hara,et al. Lack of α2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction , 2002 .
[7] M. Dewerchin,et al. Characterization and Targeting of the Murine α2-Antiplasmin Gene , 1997, Thrombosis and Haemostasis.
[8] M. Dake,et al. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel. , 2002, Journal of vascular and interventional radiology : JVIR.
[9] J. Paramo,et al. Development and clinical application of a new ELISA assay to determine plasmin–α2‐antiplasmin complexes in plasma , 1996, British journal of haematology.
[10] ToshihikoUematsu,et al. Inhibition of von Willebrand Factor Binding to Platelet GP Ib by a Fractionated Aurintricarboxylic Acid Prevents Restenosis After Vascular Injury in Hamster Carotid Artery , 1997 .
[11] J. Mills,et al. Vein adaptation to arterialization in an experimental model. , 2001, Journal of vascular surgery.
[12] B. Schlott,et al. Characterization of the interaction between plasminogen and staphylokinase. , 1994, European journal of biochemistry.
[13] O. Matsuo,et al. Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase. , 2001, Archives of biochemistry and biophysics.
[14] J. Isner,et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. , 1999, Circulation.
[15] W. Klepetko,et al. Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] P. Carmeliet,et al. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice , 1996 .
[17] K. Alitalo,et al. Signaling via vascular endothelial growth factor receptors. , 1999, Experimental cell research.
[18] A. Bayés‐Genís,et al. Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina. , 1999, Thrombosis and haemostasis.
[19] O. Kozawa,et al. Plasmin Generation Plays different Roles in the Formation and Removal of Arterial and Venous Thrombus in Mice , 2002, Thrombosis and Haemostasis.
[20] P. Carmeliet,et al. Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.
[21] P. Carmeliet,et al. Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System , 1997, Annals of the New York Academy of Sciences.
[22] J. Hartikainen,et al. Intravascular Adenovirus-Mediated VEGF-C Gene Transfer Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta , 2000, Circulation.
[23] R. Lucius,et al. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells , 2002, Journal of Neuroimmunology.
[24] M. Dewerchin,et al. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. , 1999, Blood.
[25] H. Deckmyn,et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. , 1994, Circulation.
[26] W. Risau,et al. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Wiman,et al. Molecular mechanism of physiological fibrinolysis , 1978, Nature.
[28] A. Bayés‐Genís,et al. Elevated Levels of Plasmin-α2 Antiplasmin Complexes in Unstable Angina , 1999, Thrombosis and Haemostasis.
[29] J. Isner,et al. Divergence of Angiogenic and Vascular Permeability Signaling by VEGF: Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[30] R. Ross,et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Winer,et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.
[32] O. Kozawa,et al. Differential Role of Components of the Fibrinolytic System in the Formation and Removal of Thrombus Induced by Endothelial Injury , 1999, Thrombosis and Haemostasis.